London
· Delayed Price · Currency is GBP · Price in GBXSkinBioTherapeutics Company Description
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe.
It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study.
It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets.
The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016.
SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
| Country | United Kingdom |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Stuart Ashman |
Contact Details
Address: The Core Newcastle upon Tyne, NE4 5TF United Kingdom | |
| Phone | 44 19 1495 7325 |
| Website | skinbiotherapeutics.com |
Stock Details
| Ticker Symbol | SBTX |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00BF33H870 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Stuart Ashman | Chief Executive Officer |
| Manprit Randhawa | Chief Financial Officer |